Vaneltix Pharma Overview
- Year Founded
-
1997
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Corporate
- Financing Rounds
-
6
- Investments
-
1
Vaneltix Pharma General Information
Description
Developer of therapies designed to treat urological disorders and women's health conditions. The company offers a combination product of heparin and alkalinized lidocaine, an enhanced formulation of a bladder pain drug, and regenerative therapies for bladder wall linings, enabling healthcare providers to provide immediate relief for patients suffering from interstitial cystitis and pelvic pain.
Contact Information
Website
www.vaneltix.comCorporate Office
- 317 George Street
- Suite 400
- New Brunswick, NJ 08901
- United States
Corporate Office
- 317 George Street
- Suite 400
- New Brunswick, NJ 08901
- United States
Vaneltix Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vaneltix Pharma Comparisons
Industry
Financing
Details
Vaneltix Pharma Competitors (27)
One of Vaneltix Pharma’s 27 competitors is Vertex Pharmaceuticals, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| NeRRe Therapeutics | Venture Capital-Backed | Stevenage, United Kingdom | ||||
| Supernus | Formerly VC-backed | Rockville, MD | ||||
| UCB | Corporation | Brussels, Belgium | ||||
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA |
Vaneltix Pharma Patents
Vaneltix Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018251806-A1 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | Active | 12-Apr-2017 | ||
| AU-2018251806-B2 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | Active | 12-Apr-2017 | ||
| CA-3061891-A1 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | Pending | 12-Apr-2017 | ||
| EP-3609483-A1 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | Pending | 12-Apr-2017 | ||
| EP-3609483-A4 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | Pending | 12-Apr-2017 | A61K31/727 |
Vaneltix Pharma Signals
Vaneltix Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vaneltix Pharma Acquisitions (1)
Vaneltix Pharma’s most recent deal was a Merger/Acquisition with Valentis (Pharmaceuticals). The deal was made on 16-Jul-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Valentis (Pharmaceuticals) | 16-Jul-2007 | Merger/Acquisition | Drug Discovery |
Vaneltix Pharma FAQs
-
When was Vaneltix Pharma founded?
Vaneltix Pharma was founded in 1997.
-
Where is Vaneltix Pharma headquartered?
Vaneltix Pharma is headquartered in New Brunswick, NJ.
-
What is the size of Vaneltix Pharma?
Vaneltix Pharma has 4 total employees.
-
What industry is Vaneltix Pharma in?
Vaneltix Pharma’s primary industry is Drug Discovery.
-
Is Vaneltix Pharma a private or public company?
Vaneltix Pharma is a Private company.
-
What is Vaneltix Pharma’s current revenue?
The current revenue for Vaneltix Pharma is .
-
How much funding has Vaneltix Pharma raised over time?
Vaneltix Pharma has raised $5.38M.
-
Who are Vaneltix Pharma’s investors?
Platinum-Montaur Life Sciences, Valentis (Pharmaceuticals), and University of California, San Diego have invested in Vaneltix Pharma.
-
Who are Vaneltix Pharma’s competitors?
Vertex Pharmaceuticals, NeRRe Therapeutics, Supernus, UCB, and ACADIA Pharmaceuticals are some of the 27 competitors of Vaneltix Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process